Hanxiao Xu
- Oncology top 2%
- Molecular Biology top 5%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Topics
- Cancer Cells and Metastasis (10 papers)Energy, Environment, Economic Growth (6 papers)Epigenetics and DNA Methylation (5 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Hanxiao Xu
63 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Oncology 1.6k
- Molecular Biology 1.5k
- Cancer Research 717
- Pulmonary and Respiratory Medicine 563
- Immunology 534
Countries citing papers authored by Hanxiao Xu
This map shows the geographic impact of Hanxiao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanxiao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanxiao Xu more than expected).
Fields of papers citing papers by Hanxiao Xu
This network shows the impact of papers produced by Hanxiao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanxiao Xu. The network helps show where Hanxiao Xu may publish in the future.
Co-authorship network of co-authors of Hanxiao Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Hanxiao Xu. A scholar is included among the top collaborators of Hanxiao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanxiao Xu. Hanxiao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 12 | |
| 3 | 5 | |
| 4 | 19 | |
| 5 | 6 | |
| 6 | Tumor organoids: applications in cancer modeling and potentials in precision medicinebreakdown → | 161 |
| 7 | 8 | |
| 8 | 20 | |
| 9 | 15 | |
| 10 | CD44 as a tumor biomarker and therapeutic targetbreakdown → | 266 |
| 11 | 4 | |
| 12 | 15 | |
| 13 | 249 | |
| 14 | 146 | |
| 15 | Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitorsbreakdown → | 573 |
| 16 | 124 | |
| 17 | 31 | |
| 18 | 6 | |
| 19 | 102 | |
| 20 | 72 |
About Hanxiao Xu
Hanxiao Xu is a scholar working on Oncology, Physical Therapy, Sports Therapy and Rehabilitation and Cell Biology, having authored 63 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Energy, Environment, Economic Growth (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (717 citations) and Immunology (534 citations). Hanxiao Xu has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Kongming Wu, Xun Yuan, Weiheng Zhao, Ming Yi, Qian Liu, Dechao Jiao, Hua Wu, Qian Chu, Aiguo Liu and Shiying Yu. Their work appears in journals such as PLoS ONE, Chemical Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.